Client Services:800-959-2846|Billing:949-374-5019
Client Services:800-959-2846|Billing:949-374-5019
Signed in as:
filler@godaddy.com
The therascreen BRAF test enables qualitative detection of V600E mutations in the BRAF gene. It is an FDA-approved CDx assay to identify patients with cases of metastatic colorectal cancer for whom treatment with BRAFTOVI (encorafenib) in combination with cetuximab may be appropriate.
Copyright © 2025 Emeritus Medical Technology - All Rights Reserved.